Scripscan:Venus Remedies Ltd
cmp:210
Code:526953
Story:Venus Remedies Limited engages in the research, development, manufacture, and marketing of pharmaceutical formulations in India and internationally. It primarily manufactures oncological and cephalosporin injectable products. The company provides oncology liquid injections, oncology lyophilized injections, pre-filled syringes, cephalosporins, carbapenems, and cardiology injections and liquid vials. The company, formerly known as Venus Glucose Pvt. Limited, was founded in 1989 and is headquartered in Panchkula, India.Venus reported a muted growth of 1% in revenues during Q4FY09 to Rs 634 million. On QoQ basis, revenue de-grew by 3%. Lower growth in revenue is mainly because of muted growth in exports and slow off-take (decline of 13% QoQ) by strategic partners in the domestic market. On the operating front, EBIDTA declined by 11% to Rs 149 million in Q4FY09 (Rs 167million in Q4FY08). We are also introducing FY11E estimates (EPS of Rs 69.3 in FY11E). At CMP of Rs 210,the stock is trading at 3.9x FY10E EPs of Rs 54.5. We maintain buy with a target price of Rs 275 4.4x rolling EPS of Rs 61.9.
Search This Blog(Over 800 companies covered in the blog).
Archives : Old artciles
Sunday, November 8, 2009
Important Disclaimer&Privacy policy
This blog does not share personal information with third parties nor do we store any information about your visit to this blog other than to analyze and optimize your content and reading experience through the use of cookies.You can turn off the use of cookies at anytime by changing your specific browser settings.This privacy policy is subject to change without notice and was last updated on 20.3.2013. If you have any questions, feel free to contact me directly here: arunsharemarket@gmail.com
Investment in equity shares has its own risks.Sincere efforts have been made to present the right investment perspective.The information contained herein is based on analysis and up on sources that I consider reliable. I,however,do not vouch for the accuracy or the completeness thereof.This material is for personal information and am not responsible for any loss incurred based upon it & take no responsibility whatsoever for any financial profits or loss which may arise from the recommendations above.The stock price projections shown are not necessarily indicative of future price performance.The information herein, together with all estimates and forecasts, can change without notice.
